The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Women Sexual Disorder Drugs Treating Market Research Report 2024
Synopsis
Several drugs are utilized in treating various sexual disorders in women. For instance, hypoactive sexual desire disorder (HSDD) can be addressed with medications like flibanserin (Addyi) or bremelanotide (Vyleesi), which work to increase sexual desire.
The global Women Sexual Disorder Drugs Treating market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Women Sexual Disorder Drugs Treating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Women Sexual Disorder Drugs Treating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Women Sexual Disorder Drugs Treating include Pfizer, Teva Pharmaceuticals, Duchesnay, Sprout Pharmaceuticals, Cosette Pharmaceuticals, Lupin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Women Sexual Disorder Drugs Treating, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women Sexual Disorder Drugs Treating.
The Women Sexual Disorder Drugs Treating market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Women Sexual Disorder Drugs Treating market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women Sexual Disorder Drugs Treating manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Teva Pharmaceuticals
Duchesnay
Sprout Pharmaceuticals
Cosette Pharmaceuticals
Lupin
Segment by Type
Estrogen Therapy
Ospemifene
Flibanserin
Bremelanotide
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Women Sexual Disorder Drugs Treating manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Women Sexual Disorder Drugs Treating in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Several drugs are utilized in treating various sexual disorders in women. For instance, hypoactive sexual desire disorder (HSDD) can be addressed with medications like flibanserin (Addyi) or bremelanotide (Vyleesi), which work to increase sexual desire.
The global Women Sexual Disorder Drugs Treating market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Women Sexual Disorder Drugs Treating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Women Sexual Disorder Drugs Treating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Women Sexual Disorder Drugs Treating include Pfizer, Teva Pharmaceuticals, Duchesnay, Sprout Pharmaceuticals, Cosette Pharmaceuticals, Lupin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Women Sexual Disorder Drugs Treating, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women Sexual Disorder Drugs Treating.
The Women Sexual Disorder Drugs Treating market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Women Sexual Disorder Drugs Treating market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women Sexual Disorder Drugs Treating manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Teva Pharmaceuticals
Duchesnay
Sprout Pharmaceuticals
Cosette Pharmaceuticals
Lupin
Segment by Type
Estrogen Therapy
Ospemifene
Flibanserin
Bremelanotide
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Women Sexual Disorder Drugs Treating manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Women Sexual Disorder Drugs Treating in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Women Sexual Disorder Drugs Treating Market Overview
1.1 Product Definition
1.2 Women Sexual Disorder Drugs Treating by Type
1.2.1 Global Women Sexual Disorder Drugs Treating Market Value Comparison by Type (2024-2030)
1.2.2 Estrogen Therapy
1.2.3 Ospemifene
1.2.4 Flibanserin
1.2.5 Bremelanotide
1.2.6 Others
1.3 Women Sexual Disorder Drugs Treating by Application
1.3.1 Global Women Sexual Disorder Drugs Treating Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Women Sexual Disorder Drugs Treating Market Size Estimates and Forecasts
1.4.1 Global Women Sexual Disorder Drugs Treating Revenue 2019-2030
1.4.2 Global Women Sexual Disorder Drugs Treating Sales 2019-2030
1.4.3 Global Women Sexual Disorder Drugs Treating Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Women Sexual Disorder Drugs Treating Market Competition by Manufacturers
2.1 Global Women Sexual Disorder Drugs Treating Sales Market Share by Manufacturers (2019-2024)
2.2 Global Women Sexual Disorder Drugs Treating Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Women Sexual Disorder Drugs Treating Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Women Sexual Disorder Drugs Treating, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Women Sexual Disorder Drugs Treating, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Women Sexual Disorder Drugs Treating, Product Type & Application
2.7 Global Key Manufacturers of Women Sexual Disorder Drugs Treating, Date of Enter into This Industry
2.8 Global Women Sexual Disorder Drugs Treating Market Competitive Situation and Trends
2.8.1 Global Women Sexual Disorder Drugs Treating Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Women Sexual Disorder Drugs Treating Players Market Share by Revenue
2.8.3 Global Women Sexual Disorder Drugs Treating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Women Sexual Disorder Drugs Treating Market Scenario by Region
3.1 Global Women Sexual Disorder Drugs Treating Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Women Sexual Disorder Drugs Treating Sales by Region: 2019-2030
3.2.1 Global Women Sexual Disorder Drugs Treating Sales by Region: 2019-2024
3.2.2 Global Women Sexual Disorder Drugs Treating Sales by Region: 2025-2030
3.3 Global Women Sexual Disorder Drugs Treating Revenue by Region: 2019-2030
3.3.1 Global Women Sexual Disorder Drugs Treating Revenue by Region: 2019-2024
3.3.2 Global Women Sexual Disorder Drugs Treating Revenue by Region: 2025-2030
3.4 North America Women Sexual Disorder Drugs Treating Market Facts & Figures by Country
3.4.1 North America Women Sexual Disorder Drugs Treating Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Women Sexual Disorder Drugs Treating Sales by Country (2019-2030)
3.4.3 North America Women Sexual Disorder Drugs Treating Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Women Sexual Disorder Drugs Treating Market Facts & Figures by Country
3.5.1 Europe Women Sexual Disorder Drugs Treating Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Women Sexual Disorder Drugs Treating Sales by Country (2019-2030)
3.5.3 Europe Women Sexual Disorder Drugs Treating Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Women Sexual Disorder Drugs Treating Market Facts & Figures by Region
3.6.1 Asia Pacific Women Sexual Disorder Drugs Treating Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Women Sexual Disorder Drugs Treating Sales by Region (2019-2030)
3.6.3 Asia Pacific Women Sexual Disorder Drugs Treating Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Women Sexual Disorder Drugs Treating Market Facts & Figures by Country
3.7.1 Latin America Women Sexual Disorder Drugs Treating Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Women Sexual Disorder Drugs Treating Sales by Country (2019-2030)
3.7.3 Latin America Women Sexual Disorder Drugs Treating Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Women Sexual Disorder Drugs Treating Market Facts & Figures by Country
3.8.1 Middle East and Africa Women Sexual Disorder Drugs Treating Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Women Sexual Disorder Drugs Treating Sales by Country (2019-2030)
3.8.3 Middle East and Africa Women Sexual Disorder Drugs Treating Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Women Sexual Disorder Drugs Treating Sales by Type (2019-2030)
4.1.1 Global Women Sexual Disorder Drugs Treating Sales by Type (2019-2024)
4.1.2 Global Women Sexual Disorder Drugs Treating Sales by Type (2025-2030)
4.1.3 Global Women Sexual Disorder Drugs Treating Sales Market Share by Type (2019-2030)
4.2 Global Women Sexual Disorder Drugs Treating Revenue by Type (2019-2030)
4.2.1 Global Women Sexual Disorder Drugs Treating Revenue by Type (2019-2024)
4.2.2 Global Women Sexual Disorder Drugs Treating Revenue by Type (2025-2030)
4.2.3 Global Women Sexual Disorder Drugs Treating Revenue Market Share by Type (2019-2030)
4.3 Global Women Sexual Disorder Drugs Treating Price by Type (2019-2030)
5 Segment by Application
5.1 Global Women Sexual Disorder Drugs Treating Sales by Application (2019-2030)
5.1.1 Global Women Sexual Disorder Drugs Treating Sales by Application (2019-2024)
5.1.2 Global Women Sexual Disorder Drugs Treating Sales by Application (2025-2030)
5.1.3 Global Women Sexual Disorder Drugs Treating Sales Market Share by Application (2019-2030)
5.2 Global Women Sexual Disorder Drugs Treating Revenue by Application (2019-2030)
5.2.1 Global Women Sexual Disorder Drugs Treating Revenue by Application (2019-2024)
5.2.2 Global Women Sexual Disorder Drugs Treating Revenue by Application (2025-2030)
5.2.3 Global Women Sexual Disorder Drugs Treating Revenue Market Share by Application (2019-2030)
5.3 Global Women Sexual Disorder Drugs Treating Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Women Sexual Disorder Drugs Treating Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Women Sexual Disorder Drugs Treating Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Company Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Duchesnay
6.3.1 Duchesnay Company Information
6.3.2 Duchesnay Description and Business Overview
6.3.3 Duchesnay Women Sexual Disorder Drugs Treating Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Duchesnay Women Sexual Disorder Drugs Treating Product Portfolio
6.3.5 Duchesnay Recent Developments/Updates
6.4 Sprout Pharmaceuticals
6.4.1 Sprout Pharmaceuticals Company Information
6.4.2 Sprout Pharmaceuticals Description and Business Overview
6.4.3 Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolio
6.4.5 Sprout Pharmaceuticals Recent Developments/Updates
6.5 Cosette Pharmaceuticals
6.5.1 Cosette Pharmaceuticals Company Information
6.5.2 Cosette Pharmaceuticals Description and Business Overview
6.5.3 Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolio
6.5.5 Cosette Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Company Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Women Sexual Disorder Drugs Treating Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lupin Women Sexual Disorder Drugs Treating Product Portfolio
6.6.5 Lupin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Women Sexual Disorder Drugs Treating Industry Chain Analysis
7.2 Women Sexual Disorder Drugs Treating Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Women Sexual Disorder Drugs Treating Production Mode & Process
7.4 Women Sexual Disorder Drugs Treating Sales and Marketing
7.4.1 Women Sexual Disorder Drugs Treating Sales Channels
7.4.2 Women Sexual Disorder Drugs Treating Distributors
7.5 Women Sexual Disorder Drugs Treating Customers
8 Women Sexual Disorder Drugs Treating Market Dynamics
8.1 Women Sexual Disorder Drugs Treating Industry Trends
8.2 Women Sexual Disorder Drugs Treating Market Drivers
8.3 Women Sexual Disorder Drugs Treating Market Challenges
8.4 Women Sexual Disorder Drugs Treating Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Women Sexual Disorder Drugs Treating Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Women Sexual Disorder Drugs Treating Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Women Sexual Disorder Drugs Treating Market Competitive Situation by Manufacturers in 2023
Table 4. Global Women Sexual Disorder Drugs Treating Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Women Sexual Disorder Drugs Treating Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Women Sexual Disorder Drugs Treating Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Women Sexual Disorder Drugs Treating Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Women Sexual Disorder Drugs Treating Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Women Sexual Disorder Drugs Treating, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Women Sexual Disorder Drugs Treating, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Women Sexual Disorder Drugs Treating, Product Type & Application
Table 12. Global Key Manufacturers of Women Sexual Disorder Drugs Treating, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Women Sexual Disorder Drugs Treating by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women Sexual Disorder Drugs Treating as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Women Sexual Disorder Drugs Treating Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Women Sexual Disorder Drugs Treating Sales by Region (2019-2024) & (K Units)
Table 18. Global Women Sexual Disorder Drugs Treating Sales Market Share by Region (2019-2024)
Table 19. Global Women Sexual Disorder Drugs Treating Sales by Region (2025-2030) & (K Units)
Table 20. Global Women Sexual Disorder Drugs Treating Sales Market Share by Region (2025-2030)
Table 21. Global Women Sexual Disorder Drugs Treating Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Region (2019-2024)
Table 23. Global Women Sexual Disorder Drugs Treating Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Region (2025-2030)
Table 25. North America Women Sexual Disorder Drugs Treating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Women Sexual Disorder Drugs Treating Sales by Country (2019-2024) & (K Units)
Table 27. North America Women Sexual Disorder Drugs Treating Sales by Country (2025-2030) & (K Units)
Table 28. North America Women Sexual Disorder Drugs Treating Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Women Sexual Disorder Drugs Treating Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Women Sexual Disorder Drugs Treating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Women Sexual Disorder Drugs Treating Sales by Country (2019-2024) & (K Units)
Table 32. Europe Women Sexual Disorder Drugs Treating Sales by Country (2025-2030) & (K Units)
Table 33. Europe Women Sexual Disorder Drugs Treating Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Women Sexual Disorder Drugs Treating Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Women Sexual Disorder Drugs Treating Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Women Sexual Disorder Drugs Treating Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Women Sexual Disorder Drugs Treating Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Women Sexual Disorder Drugs Treating Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Women Sexual Disorder Drugs Treating Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Women Sexual Disorder Drugs Treating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Women Sexual Disorder Drugs Treating Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Women Sexual Disorder Drugs Treating Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Women Sexual Disorder Drugs Treating Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Women Sexual Disorder Drugs Treating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Women Sexual Disorder Drugs Treating Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Women Sexual Disorder Drugs Treating Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Women Sexual Disorder Drugs Treating Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Women Sexual Disorder Drugs Treating Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Women Sexual Disorder Drugs Treating Sales (K Units) by Type (2019-2024)
Table 51. Global Women Sexual Disorder Drugs Treating Sales (K Units) by Type (2025-2030)
Table 52. Global Women Sexual Disorder Drugs Treating Sales Market Share by Type (2019-2024)
Table 53. Global Women Sexual Disorder Drugs Treating Sales Market Share by Type (2025-2030)
Table 54. Global Women Sexual Disorder Drugs Treating Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Women Sexual Disorder Drugs Treating Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Type (2019-2024)
Table 57. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Type (2025-2030)
Table 58. Global Women Sexual Disorder Drugs Treating Price (US$/Unit) by Type (2019-2024)
Table 59. Global Women Sexual Disorder Drugs Treating Price (US$/Unit) by Type (2025-2030)
Table 60. Global Women Sexual Disorder Drugs Treating Sales (K Units) by Application (2019-2024)
Table 61. Global Women Sexual Disorder Drugs Treating Sales (K Units) by Application (2025-2030)
Table 62. Global Women Sexual Disorder Drugs Treating Sales Market Share by Application (2019-2024)
Table 63. Global Women Sexual Disorder Drugs Treating Sales Market Share by Application (2025-2030)
Table 64. Global Women Sexual Disorder Drugs Treating Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Women Sexual Disorder Drugs Treating Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Application (2019-2024)
Table 67. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Application (2025-2030)
Table 68. Global Women Sexual Disorder Drugs Treating Price (US$/Unit) by Application (2019-2024)
Table 69. Global Women Sexual Disorder Drugs Treating Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Women Sexual Disorder Drugs Treating Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Women Sexual Disorder Drugs Treating Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Pharmaceuticals Company Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Duchesnay Company Information
Table 81. Duchesnay Description and Business Overview
Table 82. Duchesnay Women Sexual Disorder Drugs Treating Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Duchesnay Women Sexual Disorder Drugs Treating Product
Table 84. Duchesnay Recent Developments/Updates
Table 85. Sprout Pharmaceuticals Company Information
Table 86. Sprout Pharmaceuticals Description and Business Overview
Table 87. Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Product
Table 89. Sprout Pharmaceuticals Recent Developments/Updates
Table 90. Cosette Pharmaceuticals Company Information
Table 91. Cosette Pharmaceuticals Description and Business Overview
Table 92. Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Product
Table 94. Cosette Pharmaceuticals Recent Developments/Updates
Table 95. Lupin Company Information
Table 96. Lupin Description and Business Overview
Table 97. Lupin Women Sexual Disorder Drugs Treating Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lupin Women Sexual Disorder Drugs Treating Product
Table 99. Lupin Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Women Sexual Disorder Drugs Treating Distributors List
Table 103. Women Sexual Disorder Drugs Treating Customers List
Table 104. Women Sexual Disorder Drugs Treating Market Trends
Table 105. Women Sexual Disorder Drugs Treating Market Drivers
Table 106. Women Sexual Disorder Drugs Treating Market Challenges
Table 107. Women Sexual Disorder Drugs Treating Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Women Sexual Disorder Drugs Treating
Figure 2. Global Women Sexual Disorder Drugs Treating Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Women Sexual Disorder Drugs Treating Market Share by Type: 2023 & 2030
Figure 4. Estrogen Therapy Product Picture
Figure 5. Ospemifene Product Picture
Figure 6. Flibanserin Product Picture
Figure 7. Bremelanotide Product Picture
Figure 8. Others Product Picture
Figure 9. Global Women Sexual Disorder Drugs Treating Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Women Sexual Disorder Drugs Treating Market Share by Application: 2023 & 2030
Figure 11. Hospital Pharmacies
Figure 12. Private Clinics
Figure 13. Retail Pharmacies
Figure 14. E-Commerce (B2B)
Figure 15. E-Commerce (B2C)
Figure 16. Global Women Sexual Disorder Drugs Treating Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Women Sexual Disorder Drugs Treating Market Size (2019-2030) & (US$ Million)
Figure 18. Global Women Sexual Disorder Drugs Treating Sales (2019-2030) & (K Units)
Figure 19. Global Women Sexual Disorder Drugs Treating Average Price (US$/Unit) & (2019-2030)
Figure 20. Women Sexual Disorder Drugs Treating Report Years Considered
Figure 21. Women Sexual Disorder Drugs Treating Sales Share by Manufacturers in 2023
Figure 22. Global Women Sexual Disorder Drugs Treating Revenue Share by Manufacturers in 2023
Figure 23. Global 5 and 10 Largest Women Sexual Disorder Drugs Treating Players: Market Share by Revenue in Women Sexual Disorder Drugs Treating in 2023
Figure 24. Women Sexual Disorder Drugs Treating Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Global Women Sexual Disorder Drugs Treating Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Women Sexual Disorder Drugs Treating Sales Market Share by Country (2019-2030)
Figure 27. North America Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2019-2030)
Figure 28. United States Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Women Sexual Disorder Drugs Treating Sales Market Share by Country (2019-2030)
Figure 31. Europe Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2019-2030)
Figure 32. Germany Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Women Sexual Disorder Drugs Treating Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Women Sexual Disorder Drugs Treating Revenue Market Share by Region (2019-2030)
Figure 39. China Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Women Sexual Disorder Drugs Treating Sales Market Share by Country (2019-2030)
Figure 47. Mexico Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East and Africa Women Sexual Disorder Drugs Treating Sales Market Share by Country (2019-2030)
Figure 52. Middle East and Africa Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Women Sexual Disorder Drugs Treating Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Women Sexual Disorder Drugs Treating by Type (2019-2030)
Figure 57. Global Revenue Market Share of Women Sexual Disorder Drugs Treating by Type (2019-2030)
Figure 58. Global Women Sexual Disorder Drugs Treating Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Women Sexual Disorder Drugs Treating by Application (2019-2030)
Figure 60. Global Revenue Market Share of Women Sexual Disorder Drugs Treating by Application (2019-2030)
Figure 61. Global Women Sexual Disorder Drugs Treating Price (US$/Unit) by Application (2019-2030)
Figure 62. Women Sexual Disorder Drugs Treating Value Chain
Figure 63. Women Sexual Disorder Drugs Treating Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
